Works matching IS 20011326 AND DT 2025 AND VI 15 AND IP 1


Results: 55
    1

    Vitamin K‐dependent gamma‐carboxyglutamic acid protein 1 promotes pancreatic ductal adenocarcinoma progression through stabilizing oncoprotein KRAS and tyrosine kinase receptor EGFR.

    Published in:
    Clinical & Translational Medicine, 2025, v. 15, n. 1, p. 1, doi. 10.1002/ctm2.70191
    By:
    • Wu, Zheng;
    • Ye, Qing;
    • Zhang, Shan;
    • Hu, Li‐Peng;
    • Wang, Xiao‐Qi;
    • Yao, Lin‐Li;
    • Zhu, Lei;
    • Xiao, Shu‐Yu;
    • Duan, Zong‐Hao;
    • Zhang, Xue‐Li;
    • Jiang, Shu‐Heng;
    • Zhang, Zhi‐Gang;
    • Liu, De‐Jun;
    • Li, Dong‐Xue;
    • Yang, Xiao‐Mei
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Annexin A8 deficiency delays atherosclerosis progression.

    Published in:
    Clinical & Translational Medicine, 2025, v. 15, n. 1, p. 1, doi. 10.1002/ctm2.70176
    By:
    • Gutiérrez‐Muñoz, Carmen;
    • Blázquez‐Serra, Rafael;
    • San Sebastián‐Jaraba, Irene;
    • Sanz‐Andrea, Sandra;
    • Fernández‐Gómez, Maria J.;
    • Nuñez‐Moreno, Gonzalo;
    • Mínguez, Pablo;
    • Escolá‐Gil, Joan Carles;
    • Nogales, Paula;
    • Ollivier, Veronique;
    • Martín‐Ventura, Jose L.;
    • Ho‐Tin‐Noe, Benoit;
    • Rescher, Ursula;
    • Méndez‐Barbero, Nerea;
    • Blanco‐Colio, Luis M.
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    31
    32
    33
    34
    35
    36
    37
    38
    39

    Atezolizumab, bevacizumab, pemetrexed and platinum for EGFR‐mutant NSCLC patients after EGFR TKI failure: A phase II study with immune cell profile analysis.

    Published in:
    Clinical & Translational Medicine, 2025, v. 15, n. 1, p. 1, doi. 10.1002/ctm2.70149
    By:
    • Wu, Shang‐Gin;
    • Ho, Chao‐Chi;
    • Yang, James Chih‐Hsin;
    • Yu, Shu‐Han;
    • Lin, Yen‐Feng;
    • Lin, Shu‐Chin;
    • Liao, Bin‐Chi;
    • Yang, Ching‐Yao;
    • Lin, Yen‐Ting;
    • Yu, Chong‐Jen;
    • Chuang, Ya‐Ting;
    • Liao, Wei‐Yu;
    • Yap, Kah Yi;
    • Kou, Weng Si;
    • Shih, Jin‐Yuan
    Publication type:
    Article
    40
    41
    42
    43
    44

    Enhancement of anti‐sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2‐targeted CAR.

    Published in:
    Clinical & Translational Medicine, 2025, v. 15, n. 1, p. 1, doi. 10.1002/ctm2.70140
    By:
    • Lam, Pui Yeng;
    • Omer, Natacha;
    • Wong, Josh K. M.;
    • Tu, Cui;
    • Alim, Louisa;
    • Rossi, Gustavo R.;
    • Victorova, Maria;
    • Tompkins, Hannah;
    • Lin, Cheng‐Yu;
    • Mehdi, Ahmed M.;
    • Choo, Amos;
    • Elliott, Melissa R.;
    • Coleborn, Elaina;
    • Sun, Jane;
    • Mercer, Timothy;
    • Vittorio, Orazio;
    • Dobson, Lachlan J.;
    • McLellan, Alexander D.;
    • Brooks, Andrew;
    • Tuong, Zewen Kelvin
    Publication type:
    Article
    45
    46
    47
    48
    49
    50